Ira Shocket, MD
Gastroenterology · Washington, DCNPI 1376555771
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $531 of the $613 with a category attached, or 86.6%. 8 manufacturers reported payments, led by Bristol Myers Squibb at 38.0% of the total. 2025 is the largest year on record at $185, more than ten times the $11 reported in 2019. That places this record below the midpoint for gastroenterology clinicians in DC, where the typical reported total is $1,183.
Across 30 payments — averaging $20.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$233
- Johnson & Johnson$102
- AbbVie$88
- Boston Scientific$81
- Caris MPI, Inc.$35
- Pfizer$31
- plus $43 from 2 others
What the payments were for
- Food & beverage$53187%
- Education$8213%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 16 | $233 |
| Johnson & Johnson | 3 | $102 |
| AbbVie | 4 | $88 |
| Boston Scientific | 3 | $81 |
| Caris MPI, Inc. | 1 | $35 |
| Pfizer | 1 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $26 |
| Pentax Of America, Inc. | 1 | $17 |
How this compares
$613 in reported general payments places this provider in the 40th percentile of 77 gastroenterology providers in District of Columbia.
See all gastroenterology providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 14 | $381,993 |
| HumiraAdalimumab | 12 | $81,489 |
| Mesalamine | 34 | $39,535 |
| CreonLipase/Protease/Amylase | 15 | $31,522 |
| LinzessLinaclotide | 28 | $27,258 |
| Famotidine | 228 | $4,866 |
| Dexlansoprazole DrDexlansoprazole | 13 | $4,759 |
| Mesalamine ErMesalamine | 12 | $3,287 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 38 | $2,351 |
| Pantoprazole Sodium | 154 | $2,227 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 100 | $1,295 |
| Omeprazole | 27 | $505 |
| Escitalopram Oxalate | 15 | $396 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 20 | $305 |
| Ondansetron OdtOndansetron | 13 | $194 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $102 | $381,99314 claims |
| AbbVieHumira, Creon, Linzess | $88 | $140,26955 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 77 gastroenterology providers in District of Columbia.
Other gastroenterology in Washington
- James LewisWashington$1M
- John HoganWashington$354K
- Mark MattarWashington$349K
- Jessica KormanWashington$171K
- Mitesh PatelWashington$90K
- Sumona BhattacharyaWashington$87K
- Roshan BashirWashington$40K
- Bruce LuxonWashington$37K
- Lauren GeorgeWashington$32K
- Dominique HowardWashington$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.